Recombinant human growth hormone delivered by tissueengineered bioartificial muscle improves left ventricular function

被引：0
作者：
Rong, S. L. [1 ]
Lu, Y. X. [1 ]
Liao, Y. H. [1 ]
机构：
[1] Inst Cardiol, Lab Cardiovasc Immunol, Wuhan, Peoples R China
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2007年 / 6卷
关键词：
D O I：
10.1016/S1567-4215(07)60272-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：99 / 99
页数：1
相关论文
共 50 条
  • [41] Short-term recombinant human growth hormone administration improves respiratory function in abstinent anabolic-androgenic steroid users
    Graham, Michael R.
    Baker, Julien S.
    Evans, Peter
    Kicman, Andrew
    Cowan, David
    Hullin, David
    Davies, Bruce
    GROWTH HORMONE & IGF RESEARCH, 2007, 17 (04) : 328 - 335
  • [42] Clenbuterol improves skeletal muscle strength but not cardiac function in patients supported with a left ventricular assist device
    George, I
    Xydas, S
    Lamanca, J
    Schulman, A
    Mancini, D
    DiTullio, M
    Marboe, C
    Shane, E
    Petrilli, C
    Naka, Y
    Oz, M
    Maybaum, S
    CIRCULATION, 2005, 112 (17) : U393 - U393
  • [43] Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients
    Massimetti, C
    Pontillo, D
    Feriozzi, S
    Costantini, S
    Capezzuto, A
    Ancarani, E
    BLOOD PURIFICATION, 1998, 16 (06) : 317 - 324
  • [44] Candesartan cilexetil improves left ventricular function, left ventricular hypertrophy, and endothelial function in patients with hypertensive heart disease
    Isobe, N
    Taniguchi, K
    Oshima, S
    Ono, Z
    Adachi, H
    Toyama, T
    Naito, S
    Hoshizaki, H
    Kamiyama, H
    CIRCULATION JOURNAL, 2002, 66 (11) : 993 - 999
  • [45] Hormone replacement therapy significantly improves left ventricular diastolic functions
    Yildirir, A
    Aybar, F
    Yarali, H
    Kabakci, G
    Bükülmez, O
    Akgül, E
    Tokgözoglu, L
    Oto, A
    Gürgan, T
    HUMAN REPRODUCTION, 2000, 15 : 79 - 79
  • [46] Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist
    Ludwig, Barbara
    Rotem, Avi
    Schmid, Janine
    Weir, Gordon C.
    Colton, Clark K.
    Brendel, Mathias D.
    Neufeld, Tova
    Block, Norman L.
    Yavriyants, Karina
    Steffen, Anja
    Ludwig, Stefan
    Chavakis, Triantafyllos
    Reichel, Andreas
    Azarov, Dimitri
    Zimermann, Baruch
    Maimon, Shiri
    Balyura, Mariya
    Rozenshtein, Tania
    Shabtay, Noa
    Vardi, Pnina
    Bloch, Konstantin
    de Vos, Paul
    Schally, Andrew V.
    Bornstein, Stefan R.
    Barkai, Uriel
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (13) : 5022 - 5027
  • [47] Detection of doping with recombinant human growth hormone
    He, Chunji
    Wu, Moutian
    BIOANALYSIS, 2009, 1 (05) : 953 - 965
  • [48] Naevocyte triggering by recombinant human growth hormone
    Pierard, GE
    PierardFranchimont, C
    Nikkels, A
    NikkelsTassoudji, N
    Arrese, JE
    Bourguignon, JP
    JOURNAL OF PATHOLOGY, 1996, 180 (01) : 74 - 79
  • [49] EFFECT OF RECOMBINANT HUMAN GROWTH-HORMONE ON ADRENOCORTICAL FUNCTION, AND ON SODIUM AND POTASSIUM HOMEOSTASIS
    PRATT, JH
    PEACOCK, M
    HENRY, DP
    PHARMACOLOGY, 1993, 47 (01) : 36 - 42
  • [50] Growth hormone deficiency in adults and clinical use of recombinant human growth hormone
    Wang, ZL
    CHINESE MEDICAL JOURNAL, 1999, 112 (03) : 195 - 201
12345